Ryan Hartman Appointed To Chief Commercial Officer Of Trice Medical

Ryan Hartman brings with him over twenty years of healthcare experience, of which the last nineteen years were with Boston Scientific.

He received his Bachelor of Arts from SUNY, New Paltz and his Master of Science from New School University.

He will be responsible for developing and executing the Global Marketing strategy including; Health Economics and Reimbursement, Clinical Strategy and Product Development across Trice Medical’s growing, innovative business.

Over the course of his career, Mr. Hartman advanced through multiple leadership roles within Sales, Marketing and Market Development.  In his most recent position as Vice President for Single-Use Scopes and Global Markets, Mr. Hartman was instrumental in positioning Boston Scientific as a global leader in the Gastrointestinal Single Use Endoscopy space, where he led a team that would be the first to launch several disruptive disposable endoscopes.

Trice Medical is known for its disruptive imaging technology that enables orthopedic procedures to be performed on its portable, tablet-based system. Trice developed the world’s first and only platform that combines a disposable needle camera (mi-eye™) with a high-quality 15mghz ultrasound transducer (mi-ultra™).

In 2020, Trice launched a fully-disposable endoscopic carpal tunnel system with the disposable mi-eye angled camera, making Trice the first company in the world to enable surgeons to perform this procedure anywhere: in the operating room; a procedure room; or in the office.

In 2021, Trice acquired Tenex Health, whose cutting-edge, minimally invasive technology improves overall functionality and significantly decreases pain, by precisely targeting and removing damaged tissue and bone without the need for conventional surgery.

“Ryan is a visionary, innovative, thoughtful and patient centric leader in the industry. His background with regards to understanding the market opportunities for small, disposable cameras is a perfect match for where our business is headed,” said CEO and President, Mark Foster. “Trice is building a large business in small procedures and we are looking forward to Ryan’s contributions.”

“We are at the very beginning of a massive wave of change in the way disposable cameras will be used, to unlock value throughout the global healthcare world.  Many of these future innovations will enable healthcare providers to deliver better patient outcomes, with more efficiency.  I am very excited to join the talented team at Trice to help bring their vision to life,” said Chief Commercial Officer, Ryan Hartman.

Hot this week

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”

Avery Dennison Medical Introduces Ipdated SilFoam Lite: Sustainability, MDR Certification & Performance Improvements

The newly enhanced SilFoam Lite delivers superior efficiency and reliability, bringing improved fluid handling capabilities and improved tack. These improvements make the product ideal for customers seeking quality, high-performance solutions in wound care notes Avery Dennison Medical.

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution